CUSIP 30049G302COMEVOKQ3 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ3 2025
15 funds hold this security · Q3 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 159.4K | $792.0K | +159.3K | Added |
| 2 | Nantahala Capital Management, LLC | 148.2K | $736.3K | 0 | Held |
| 3 | Bleichroeder LP | 146.4K | $727.6K | +77.6K | Added |
| 4 | National Wealth Management Group, LLC | 80.1K | $398.2K |
| +80.1K |
| New |
| 5 | Drw Securities, LLC | 23.7K | $118.0K | +23.7K | New |
| 6 | Vanguard Group Inc | 18.8K | $93.2K | +18.8K | New |
| 7 | Two Sigma Securities, LLC | 10.4K | $51.9K | +10.4K | New |
| 8 | Osaic Holdings, Inc. | 3.0K | $16.4K | +3.0K | New |
| 9 | Northwestern Mutual Wealth Management Co | 272 | $1.4K | +272 | New |
| 10 | Royal Bank Of Canada | 190 | $1.0K | +190 | New |
See every fund holding Evoke Pharma Inc, with full quarter-over-quarter share changes.
Unlock all holders